These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 10812767

  • 1. Quinupristin/dalfopristin: a treatment option for vancomycin-resistant Enterococci.
    Kim MK, Nicolau DP, Nightingale CH, Quintiliani R.
    Conn Med; 2000 Apr; 64(4):209-12. PubMed ID: 10812767
    [No Abstract] [Full Text] [Related]

  • 2. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
    Winston DJ, Emmanouilides C, Kroeber A, Hindler J, Bruckner DA, Territo MC, Busuttil RW.
    Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685
    [Abstract] [Full Text] [Related]

  • 3. Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium.
    Lorian V, Fernandes F.
    Drugs Exp Clin Res; 1998 May; 24(2):73-6. PubMed ID: 9675547
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of vancomycin-resistant enterococci, with a focus on quinupristin-dalfopristin.
    Fuller RE, Drew RH, Perfect JR.
    Pharmacotherapy; 1996 May; 16(4):584-92. PubMed ID: 8840364
    [Abstract] [Full Text] [Related]

  • 6. Use of streptogramin growth promoters in poultry and isolation of streptogramin-resistant Enterococcus faecium from humans.
    Kieke AL, Borchardt MA, Kieke BA, Spencer SK, Vandermause MF, Smith KE, Jawahir SL, Belongia EA, Marshfield Enterococcal Study Group.
    J Infect Dis; 2006 Nov 01; 194(9):1200-8. PubMed ID: 17041845
    [Abstract] [Full Text] [Related]

  • 7. Vancomycin-resistant Enterococcus faecium osteomyelitis: successful treatment with quinupristin-dalfopristin.
    Summers M, Misenhimer GR, Antony SJ.
    South Med J; 2001 Mar 01; 94(3):353-5. PubMed ID: 11284529
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999.
    Johnson AP, Warner M, Hallas G, Livermore DM.
    J Antimicrob Chemother; 2000 Jul 01; 46(1):125-8. PubMed ID: 10882701
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial activity of quinupristin-dalfopristin combined with other antibiotics against vancomycin-resistant enterococci.
    Eliopoulos GM, Wennersten CB.
    Antimicrob Agents Chemother; 2002 May 01; 46(5):1319-24. PubMed ID: 11959562
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L, Nicola L, De Vecchi E.
    Clin Microbiol Infect; 2008 Jun 01; 14(6):608-11. PubMed ID: 18397336
    [Abstract] [Full Text] [Related]

  • 16. Quinupristin/dalfopristin.
    Med Lett Drugs Ther; 1999 Nov 19; 41(1066):109-10. PubMed ID: 10987009
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
    Baysallar M, Kilic A, Aydogan H, Cilli F, Doganci L.
    Int J Antimicrob Agents; 2004 May 19; 23(5):510-2. PubMed ID: 15120733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.